Cargando…
Resurgence of hypertension and cardiovascular diseases in patients recovered from COVID-19: An Indian perspective
OBJECTIVE: The aim of this study was to understand the prevalence, extent, clinical approach of hypertension and cardiovascular disease (CVD) in patients recovered from COVID-19. METHODS: The round table meetings (RTMs) and survey convened a diverse panel of specialists including cardiologists, endo...
Autores principales: | Krishnakumar, Bhaskaran, Christopher, Johann, Prasobh, P. Sunil, Godbole, Shreerang, Mehrotra, Anurag, Singhal, Anurag, Roy, Satrajit, Bhattacharya, Kuntal, Kolte, Narendra, Abhyankar, Mahesh V., Revankar, Santosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480725/ https://www.ncbi.nlm.nih.gov/pubmed/36119181 http://dx.doi.org/10.4103/jfmpc.jfmpc_973_21 |
Ejemplares similares
-
Risk Factors and Comorbidities in Young Indian Patients with Hypertension: REAL YOUNG (Hypertension) Study
por: Desai, Nagaraj, et al.
Publicado: (2021) -
Management of polycystic ovary syndrome among Indian women using myo‐inositol and D-chiro-inositol
por: Vyas, Lila, et al.
Publicado: (2022) -
Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study
por: Iyengar, S. S., et al.
Publicado: (2020) -
Challenges and practice pattern of dyslipidaemia management in India during COVID-19 pandemic: A cross-sectional survey
por: Abhyankar, Mahesh V., et al.
Publicado: (2020) -
Clinical data analysis of telmisartan for hypertension management in Indian population
por: Prem Kumar, A, et al.
Publicado: (2021)